Literature DB >> 23589577

Giardia duodenalis arginine deiminase modulates the phenotype and cytokine secretion of human dendritic cells by depletion of arginine and formation of ammonia.

Stefanie Banik1, Pablo Renner Viveros, Frank Seeber, Christian Klotz, Ralf Ignatius, Toni Aebischer.   

Abstract

Depletion of arginine is a recognized strategy that pathogens use to evade immune effector mechanisms. Depletion depends on microbial enzymes such as arginases, which are considered virulence factors. The effect is mostly interpreted as being a consequence of successful competition with host enzymes for the substrate. However, both arginases and arginine deiminases (ADI) have been associated with pathogen virulence. Both deplete arginine, but their reaction products differ. An ADI has been implicated in the virulence of Giardia duodenalis, an intestinal parasite that infects humans and animals, causing significant morbidity. Dendritic cells (DC) play a critical role in host defense and also in a murine G. duodenalis infection model. The functional properties of these innate immune cells depend on the milieu in which they are activated. Here, the dependence of the response of these cells on arginine was studied by using Giardia ADI and lipopolysaccharide-stimulated human monocyte-derived DC. Arginine depletion by ADI significantly increased tumor necrosis factor alpha and decreased interleukin-10 (IL-10) and IL-12p40 secretion. It also reduced the upregulation of surface CD83 and CD86 molecules, which are involved in cell-cell interactions. Arginine depletion also reduced the phosphorylation of S6 kinase in DC, suggesting the involvement of the mammalian target of rapamycin signaling pathway. The changes were due to arginine depletion and the formation of reaction products, in particular, ammonium ions. Comparison of NH(4)(+) and urea revealed distinct immunomodulatory activities of these products of deiminases and arginases, respectively. The data suggest that a better understanding of the role of arginine-depleting pathogen enzymes for immune evasion will have to take enzyme class and reaction products into consideration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23589577      PMCID: PMC3697621          DOI: 10.1128/IAI.00004-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

Review 1.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria.

Authors:  M Rescigno; M Urbano; B Valzasina; M Francolini; G Rotta; R Bonasio; F Granucci; J P Kraehenbuhl; P Ricciardi-Castagnoli
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

3.  [The role of cytokines in giardiasis in children].

Authors:  Elzbieta Maciorkowska; Maciej Kaczmarski; Andrzej Kemona
Journal:  Med Wieku Rozwoj       Date:  2005 Oct-Dec

4.  Nitric oxide production by human intestinal epithelial cells and competition for arginine as potential determinants of host defense against the lumen-dwelling pathogen Giardia lamblia.

Authors:  L Eckmann; F Laurent; T D Langford; M L Hetsko; J R Smith; M F Kagnoff; F D Gillin
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

Review 5.  Immune response to Giardia duodenalis.

Authors:  G Faubert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 6.  Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms.

Authors:  Ingrid Ordás; Diane R Mould; Brian G Feagan; William J Sandborn
Journal:  Clin Pharmacol Ther       Date:  2012-02-22       Impact factor: 6.875

7.  Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology.

Authors:  D Kontoyiannis; A Kotlyarov; E Carballo; L Alexopoulou; P J Blackshear; M Gaestel; R Davis; R Flavell; G Kollias
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

8.  L-asparaginase II produced by Salmonella typhimurium inhibits T cell responses and mediates virulence.

Authors:  Amy L Kullas; Michael McClelland; Hee-Jeong Yang; Jason W Tam; AnnMarie Torres; Steffen Porwollik; Patricio Mena; Joseph B McPhee; Lydia Bogomolnaya; Helene Andrews-Polymenis; Adrianus W M van der Velden
Journal:  Cell Host Microbe       Date:  2012-12-13       Impact factor: 21.023

9.  Arginine consumption by the intestinal parasite Giardia intestinalis reduces proliferation of intestinal epithelial cells.

Authors:  Britta Stadelmann; María C Merino; Lo Persson; Staffan G Svärd
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

10.  Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement.

Authors:  Marcello Chieppa; Maria Rescigno; Alex Y C Huang; Ronald N Germain
Journal:  J Exp Med       Date:  2006-12-04       Impact factor: 14.307

View more
  22 in total

Review 1.  Targeting innate immunity for neurodegenerative disorders of the central nervous system.

Authors:  Katrin I Andreasson; Adam D Bachstetter; Marco Colonna; Florent Ginhoux; Clive Holmes; Bruce Lamb; Gary Landreth; Daniel C Lee; Donovan Low; Marina A Lynch; Alon Monsonego; M Kerry O'Banion; Milos Pekny; Till Puschmann; Niva Russek-Blum; Leslie A Sandusky; Maj-Linda B Selenica; Kazuyuki Takata; Jessica Teeling; Terrence Town; Linda J Van Eldik
Journal:  J Neurochem       Date:  2016-09       Impact factor: 5.372

Review 2.  Interactions of Giardia sp. with the intestinal barrier: Epithelium, mucus, and microbiota.

Authors:  Thibault Allain; Christina B Amat; Jean-Paul Motta; Anna Manko; André G Buret
Journal:  Tissue Barriers       Date:  2017-01-03

3.  Treatment of giardiasis: current status and future directions.

Authors:  Richard R Watkins; Lars Eckmann
Journal:  Curr Infect Dis Rep       Date:  2014-02       Impact factor: 3.725

4.  Giardia duodenalis cathepsin B proteases degrade intestinal epithelial interleukin-8 and attenuate interleukin-8-induced neutrophil chemotaxis.

Authors:  James A Cotton; Amol Bhargava; Jose G Ferraz; Robin M Yates; Paul L Beck; Andre G Buret
Journal:  Infect Immun       Date:  2014-04-14       Impact factor: 3.441

5.  Giardia lamblia: identification of molecules that contribute to direct mast cell activation.

Authors:  Samira Muñoz-Cruz; Argelia Gomez-García; Félix Matadamas-Martínez; Juan A Alvarado-Torres; Patricia Meza-Cervantez; Lourdes Arriaga-Pizano; Lilián Yépez-Mulia
Journal:  Parasitol Res       Date:  2018-06-02       Impact factor: 2.289

Review 6.  The Road Less Traveled? Unconventional Protein Secretion at Parasite-Host Interfaces.

Authors:  Erina A Balmer; Carmen Faso
Journal:  Front Cell Dev Biol       Date:  2021-05-24

Review 7.  Advances in understanding Giardia: determinants and mechanisms of chronic sequelae.

Authors:  Luther A Bartelt; R Balfour Sartor
Journal:  F1000Prime Rep       Date:  2015-05-26

Review 8.  Drug Development Against the Major Diarrhea-Causing Parasites of the Small Intestine, Cryptosporidium and Giardia.

Authors:  Yukiko Miyamoto; Lars Eckmann
Journal:  Front Microbiol       Date:  2015-11-19       Impact factor: 5.640

9.  Giardia duodenalis infection reduces granulocyte infiltration in an in vivo model of bacterial toxin-induced colitis and attenuates inflammation in human intestinal tissue.

Authors:  James A Cotton; Jean-Paul Motta; L Patrick Schenck; Simon A Hirota; Paul L Beck; Andre G Buret
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

10.  The role of arginine and arginine-metabolizing enzymes during Giardia - host cell interactions in vitro.

Authors:  Britta Stadelmann; Kurt Hanevik; Mattias K Andersson; Oystein Bruserud; Staffan G Svärd
Journal:  BMC Microbiol       Date:  2013-11-14       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.